A Study of Abemaciclib in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Abemaciclib in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
Dissection of the Gastrointestinal-mediated Glucose Disposal and Incretin Defect in Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- NA
A Study of Lanabecestat (LY3314814) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
An Euglycemic Clamp Trial to Evaluate Pharmacokinetics of Single Doses of BioChaperone Insulin Lispro in Healthy Japanese Subjects
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3039478 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
LY2510924, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Various Formulations of LY900014 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis Naive to Systemic Treatment
- Status
- COMPLETED
- Phase
- PHASE3
Master Rollover Protocol for Continued Safety Assessment of Study Drug
- Status
- AVAILABLE
- Phase
- N/A
Empagliflozin and ACEi- Effects on Hyperfiltration: BETWEEN Study
- Status
- COMPLETED
- Phase
- PHASE2
A Study of LY3337641 in Rheumatoid Arthritis
- Status
- TERMINATED
- Phase
- PHASE2
A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or AD
- Status
- COMPLETED
- Phase
- PHASE1
2nd Line Treatment With Pemetrexed and Sorafenib for Recurrent or Metastatic Triple Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of a Novel Insulin Lispro Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin Pumps
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study of a New Type of Insulin in Participants With Type 2 Diabetes on Insulin Injection Therapy
- Status
- WITHDRAWN
- Phase
- PHASE1